Name: PPCB Shares Authorized 2011-2026
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

PROPANC BIOPHARMA, INC. Shares Authorized

PROPANC BIOPHARMA, INC. (PPCB) had Shares Authorized of 10.00 billion shares as of 2026-03-31, per its S-1 filed 2026-07-17.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-07-17

2026-03-31: Common Stock, Shares Authorized 10.00B shares.
2025-12-31: Common Stock, Shares Authorized 10.00B shares.
2025-09-30: Common Stock, Shares Authorized 10.00B shares.
2025-06-30: Common Stock, Shares Authorized 10.00B shares.

Period end	Common Stock, Shares Authorized	Common Stock, Shares Authorized as first filed
2026-03-31	10.00B shares S-1 · filed 2026-07-17
2025-12-31	10.00B shares S-1 · filed 2026-04-10
2025-09-30	10.00B shares 10-Q · filed 2025-11-14
2025-06-30	10.00B shares S-1 · filed 2026-07-17
2025-03-31	10.00B shares 10-Q · filed 2025-05-15
2024-12-31	10.00B shares 10-Q · filed 2025-02-14
2024-09-30	10.00B shares 10-Q · filed 2024-11-14
2024-06-30	10.00B shares S-1 · filed 2026-07-17
2024-03-31	10.00B shares 10-Q · filed 2024-05-15
2023-12-31	10.00B shares 10-Q · filed 2024-02-20
2023-09-30	10.00B shares 10-Q · filed 2023-11-14
2023-06-30	10.00B shares 10-K · filed 2024-09-30
2023-03-31	10.00B shares 10-Q · filed 2023-05-15
2022-12-31	10.00B shares 10-Q · filed 2023-02-10
2022-09-30	10.00B shares 10-Q · filed 2022-11-14
2022-09-21	10.00B shares 10-Q · filed 2024-11-14
2022-09-20	3.00B shares 10-Q · filed 2024-11-14
2022-06-30	10.00B shares 10-K · filed 2023-09-28	3.00B shares 10-K · filed 2022-09-28
2022-05-18	3.00B shares 10-Q · filed 2024-11-14
2022-05-17	1.00B shares 10-Q · filed 2024-11-14
2022-03-31	1.00B shares 10-Q · filed 2022-05-16
2021-12-31	1.00B shares 10-Q · filed 2022-02-14
2021-10-31	2.00M shares 10-Q · filed 2021-11-12
2021-09-30	1.00B shares 10-Q · filed 2021-11-12
2021-06-30	3.00B shares 10-K · filed 2022-09-28	1.00B shares 10-K · filed 2021-09-28
2021-03-31	1.00B shares 10-Q · filed 2021-05-14
2021-02-04	1.00B shares 10-Q · filed 2021-11-12
2021-02-03	100.00M shares 10-Q · filed 2021-11-12
2020-12-31	1.00B shares 10-Q · filed 2021-02-12
2020-09-30	1.00B shares 10-Q · filed 2020-11-16
2020-06-30	1.00B shares 10-K · filed 2021-09-28
2020-03-31	1.00B shares 10-Q · filed 2020-05-15
2020-02-06	1.00B shares 10-K · filed 2020-10-01
2020-02-04	1.00B shares 10-Q · filed 2022-05-16
2020-02-03	100.00M shares 10-Q · filed 2022-05-16
2019-12-31	100.00M shares 10-Q · filed 2020-02-14
2019-09-30	100.00M shares 10-Q · filed 2019-11-14
2019-07-24	100.00M shares 10-Q · filed 2019-11-14
2019-06-30	1.00B shares 10-K · filed 2020-10-01	100.00M shares 10-K · filed 2019-10-15
2019-06-24	100.00M shares 10-K · filed 2020-10-01
2019-03-31	4.00B shares 10-Q · filed 2019-05-15
2018-12-31	4.00B shares 10-Q · filed 2019-02-14
2018-09-30	4.00B shares 10-Q · filed 2018-11-13
2018-09-21	4.00B shares 10-K · filed 2019-10-15	400.00M shares 10-Q · filed 2019-05-15
2018-09-20	400.00M shares 10-K · filed 2019-10-15
2018-06-30	100.00M shares 10-K · filed 2019-10-15	400.00M shares 10-K · filed 2018-09-17
2018-03-31	400.00M shares 10-Q · filed 2018-05-10
2018-01-23	400.00M shares 10-K · filed 2019-10-15
2018-01-22	100.00M shares 10-K · filed 2019-10-15
2017-12-31	400.00M shares 10-Q · filed 2018-02-09
2017-09-30	100.00M shares 10-Q · filed 2017-11-09
2017-06-30	400.00M shares 10-K · filed 2018-09-17	100.00M shares 10-K · filed 2017-09-28
2017-04-20	100.00M shares 10-K · filed 2018-09-17
2017-03-31	100.00M shares 10-Q · filed 2017-05-08
2016-12-31	2.00B shares 10-Q · filed 2017-02-14
2016-09-30	2.00B shares 10-Q · filed 2016-11-10
2016-06-30	100.00M shares 10-K · filed 2017-09-28	2.00B shares 10-K · filed 2016-09-28
2016-03-31	2.00B shares 10-Q · filed 2016-05-16
2015-12-31	2.00B shares 10-Q · filed 2016-02-16
2015-09-30	2.00B shares 10-Q · filed 2015-11-16
2015-07-10	10.00B shares 10-K · filed 2016-09-28
2015-06-30	2.00B shares 10-K · filed 2016-09-28
2015-03-31	10.00B shares 10-Q · filed 2015-05-15
2014-12-31	10.00B shares 10-Q · filed 2015-02-17
2014-11-12	100.00M shares 10-K · filed 2016-09-28
2014-09-30	100.00M shares 10-Q · filed 2014-11-19
2014-06-30	2.00B shares 10-K · filed 2015-09-30	100.00M shares 10-K · filed 2014-10-14
2014-03-31	100.00M shares 10-Q · filed 2014-05-20
2013-12-31	100.00M shares 10-Q · filed 2014-02-14
2013-09-30	100.00M shares 10-Q · filed 2013-11-14
2013-06-30	100.00M shares 10-K · filed 2014-10-14
2013-03-31	100.00M shares 10-Q · filed 2013-05-20
2012-12-31	100.00M shares 10-Q · filed 2013-02-20
2012-09-30	100.00M shares 10-Q · filed 2012-11-19
2012-06-30	100.00M shares 10-K · filed 2013-10-15
2012-03-31	100.00M shares 10-Q · filed 2012-05-21
2011-12-31	100.00M shares 10-Q/A · filed 2012-03-07
2011-06-30	100.00M shares 10-K · filed 2012-10-15

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CHINA PHARMA HOLDINGS, INC. (CPHI)		$0.032B
NANOVIRICIDES, INC. (NNVC)	United States	$0.031B
BeyondSpring Inc. (BYSI)	United States	$0.031B	-10.95
Context Therapeutics Inc. (CNTX)	United States	$0.034B	-1.10
ROCKWELL MEDICAL, INC. (RMTI)	United States	$0.035B
IGC Pharma, Inc. (IGC)	United States	$0.029B	-5.98
Hepion Pharmaceuticals, Inc. (HEPA)	United States	$0.029B	-0.62
Transcode Therapeutics, Inc. (RNAZ)	United States	$0.029B	-0.12
MIRA PHARMACEUTICALS, INC. (MIRA)	United States	$0.036B	-4.30
Seres Therapeutics, Inc. (MCRB)	United States	$0.036B	-3.45